The Mesothelioma Center News - Page 2
Study to Clarify Radiation Benefits in Mesothelioma Patients
- by Tim Povtak
- Research & Clinical Trials
- Mar 3, 2020
An upcoming phase III clinical trial involving the National Cancer Institute should clarify the still-debatable benefits of using radiotherapy in combination with aggressive surgery for patients with pleural mesothelioma.
Read More
Revlon Named in Talc-Mesothelioma Lawsuit
- by Tim Povtak
- Asbestos Exposure & Bans
- Feb 26, 2020
Revlon Inc. on Tuesday became the latest corporation hit with a lawsuit alleging asbestos-contaminated talc in its cosmetic products caused mesothelioma cancer in a woman. A Maryland couple filed the…
Read More
Mesothelioma Clinical Trial Involves Immunotherapy Before Surgery
- by Tim Povtak
- Research & Clinical Trials
- Feb 24, 2020
Three of the country’s leading cancer centers have opened a collaborative clinical trial that potentially could change surgical treatment of mesothelioma. Researchers will measure the safety and efficacy…
Read More
Mesothelioma Detection May Come Earlier with Liquid Biopsy
- by Tim Povtak
- Treatment & Doctors
- Feb 18, 2020
Cellular Analytics, a biotechnology company in Ontario, Canada, has unveiled a novel liquid biopsy test for mesothelioma that could lead to more effective management of this rare cancer.
Read More
Mesothelioma Gene Therapy Trial Shows ‘Real Potential’
- by Tim Povtak
- Research & Clinical Trials
- Feb 17, 2020
Gene therapy is moving closer to becoming part of standard-of-care treatment for pleural mesothelioma, according to the latest multicenter clinical trial. The phase III trial, known as the…
Read More
Alternative to Alimta Coming for Mesothelioma Patients
- by Tim Povtak
- Treatment & Doctors
- Feb 12, 2020
The U.S. Food and Drug Administration has granted final approval of Pemfexy, a new brand of the chemotherapy drug pemetrexed, to combat malignant mesothelioma and advanced stage non-small…
Read More
FDA Moves Closer to Standardized Testing for Asbestos in Talc
- by Tim Povtak
- Asbestos Exposure & Bans
- Feb 5, 2020
The U.S. Food and Drug Administration moved closer on Tuesday to formulating standardized testing of talc-based products for the presence of toxic asbestos fibers. Experts from eight different federal…
Read More
Duke Completes Largest Study of Mesothelioma in Women
- by Tim Povtak
- Research & Clinical Trials
- Feb 5, 2020
Women diagnosed with peritoneal mesothelioma were 10 years younger on average than those with pleural mesothelioma in a recent case study at the Duke University Medical Center. It was the…
Read More
Mesothelioma Deaths Peak 30 Years After Asbestos Ban
- by Tim Povtak
- Asbestos Exposure & Bans
- Jan 30, 2020
Almost 30 years after Italy passed sweeping legislation that banned the mining, use and commercialization of asbestos, the country is facing the peak of its mesothelioma cancer crisis. The…
Read More
ONCOS-102 Shows Promise in Combination Mesothelioma Treatment
- by Tim Povtak
- Research & Clinical Trials
- Jan 27, 2020
ONCOS-102, a promising immunotherapy vaccine, is moving closer to becoming a part of future first-line treatment for mesothelioma. Early clinical trial results announced this week show safety and…
Read More
